The Global Pertuzumab Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 4.93 Billion by 2032, growing at a CAGR of 52.2% (2025-2032).
The Global Pertuzumab Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 4.93 Billion by 2032, growing at a CAGR of 52.2% (2025-2032).